- Home
- GLU vs ME Comparison
GLU vs ME Comparison
Compare GLU & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLU
- ME
- Stock Information
- Founded
- GLU 2004
- ME 2006
- Country
- GLU United States
- ME United States
- Employees
- GLU N/A
- ME N/A
- Industry
- GLU Finance/Investors Services
- ME Precision Instruments
- Sector
- GLU Finance
- ME Health Care
- Exchange
- GLU Nasdaq
- ME Nasdaq
- Market Cap
- GLU 99.0M
- ME 98.7M
- IPO Year
- GLU N/A
- ME N/A
- Fundamental
- Price
- GLU $15.11
- ME $3.58
- Analyst Decision
- GLU
- ME Hold
- Analyst Count
- GLU 0
- ME 1
- Target Price
- GLU N/A
- ME $9.40
- AVG Volume (30 Days)
- GLU 12.4K
- ME 226.1K
- Earning Date
- GLU 01-01-0001
- ME 02-05-2025
- Dividend Yield
- GLU 8.60%
- ME N/A
- EPS Growth
- GLU N/A
- ME N/A
- EPS
- GLU 0.62
- ME N/A
- Revenue
- GLU N/A
- ME $193,260,000.00
- Revenue This Year
- GLU N/A
- ME $21.93
- Revenue Next Year
- GLU N/A
- ME $17.31
- P/E Ratio
- GLU $22.50
- ME N/A
- Revenue Growth
- GLU N/A
- ME N/A
- 52 Week Low
- GLU $11.61
- ME $2.66
- 52 Week High
- GLU $15.40
- ME $16.52
- Technical
- Relative Strength Index (RSI)
- GLU 45.04
- ME 49.65
- Support Level
- GLU $14.62
- ME $3.34
- Resistance Level
- GLU $15.25
- ME $3.95
- Average True Range (ATR)
- GLU 0.31
- ME 0.29
- MACD
- GLU 0.03
- ME 0.02
- Stochastic Oscillator
- GLU 55.56
- ME 41.75
About GLU Gabelli Global Utility of Beneficial Ownership
Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.